BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND CALR, ENSG00000179218, 811, P27797, SSA, RO, FLJ26680, cC1qR AND Prognosis
53 results:

  • 1. Upregulation of CALD1 predicted a poor prognosis for platinum-treated ovarian cancer and revealed it as a potential therapeutic resistance target.
    Li W; Huang L; Qi N; Zhang Q; Qin Z
    BMC Genomics; 2024 Feb; 25(1):183. PubMed ID: 38365611
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Immunological characteristics of immunogenic cell death genes and malignant progression driving roles of TLR4 in anaplastic thyroid carcinoma.
    Xu T; Zhu C; Song F; Zhang W; Yuan M; Pan Z; Huang P
    BMC Cancer; 2023 Nov; 23(1):1131. PubMed ID: 37990304
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Optimal first-line treatment strategies of systemic therapy for unresectable gastrointestinal neuroendocrine tumors based on the opinions of Japanese experts.
    Honma Y; Ikeda M; Hijioka S; Matsumoto S; Ito T; Aoki T; Furuse J
    Invest New Drugs; 2023 Dec; 41(6):777-786. PubMed ID: 37856005
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Evaluation of progression-free survival as a surrogate endpoint for overall survival in locally advanced or metastatic differentiated thyroid cancer: a systematic review.
    Yang S; Zhan J; Xu X
    Endocrine; 2023 Dec; 82(3):491-497. PubMed ID: 37702900
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Inhibition of CDK1 by RO-3306 Exhibits Anti-Tumorigenic Effects in Ovarian cancer Cells and a Transgenic Mouse Model of Ovarian cancer.
    Huang Y; Fan Y; Zhao Z; Zhang X; Tucker K; Staley A; Suo H; Sun W; Shen X; Deng B; Pierce SR; West L; Yin Y; Emanuele MJ; Zhou C; Bae-Jump V
    Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569750
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. A Proposed Modified Staging System for Medullary Thyroid cancer: A SEER Analysis With Multicenter Validation.
    Wang Z; Fan X; Zha X; Xu Y; Yin Z; Rixiati Y; Yu F
    Oncologist; 2024 Jan; 29(1):e59-e67. PubMed ID: 37311049
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Comparison of the cox regression to machine learning in predicting the survival of anaplastic thyroid carcinoma.
    Xu L; Cai L; Zhu Z; Chen G
    BMC Endocr Disord; 2023 Jun; 23(1):129. PubMed ID: 37291551
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Hyperthermic intraperitoneal chemotherapy for epithelial ovarian cancer: A meta-analysis.
    Kim SI; Kim JH; Lee S; Cho H; van Driel WJ; Sonke GS; Bristow RE; Park SY; Fotopoulou C; Lim MC
    Gynecol Oncol; 2022 Dec; 167(3):547-556. PubMed ID: 36273925
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [Modern molecular and imaging diagnostics in pancreatic neuroendocrine neoplasms].
    Chiapponi C; Bruns CJ
    Chirurgie (Heidelb); 2022 Aug; 93(8):731-738. PubMed ID: 35913626
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Intraoperative lidocaine infusion in patients undergoing pancreatectomy for pancreatic cancer: a mechanistic, multicentre randomised clinical trial.
    Zhang H; Qu M; Guo K; Wang Y; Gu J; Wu H; Zhu X; Sun Z; Cata JP; Chen W; Miao C
    Br J Anaesth; 2022 Aug; 129(2):244-253. PubMed ID: 35697547
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Real-world comparison of healthcare resource utilization and costs of [
    Cox T; O'Connell M; Leeuwenkamp O; Palimaka S; Reed N
    Curr Med Res Opin; 2022 Aug; 38(8):1305-1317. PubMed ID: 35418254
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Construction of a Diagnostic Model for Lymph Node Metastasis of the Papillary Thyroid Carcinoma Using Preoperative Ultrasound Features and Imaging Omics.
    Zhang C; Cheng L; Zhu W; Zhuang J; Zhao T; Li X; Wang W
    J Healthc Eng; 2022; 2022():1872412. PubMed ID: 35178222
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Autophagic Schwann cells promote perineural invasion mediated by the NGF/ATG7 paracrine pathway in pancreatic cancer.
    Zhang W; He R; Yang W; Zhang Y; Yuan Q; Wang J; Liu Y; Chen S; Zhang S; Zhang W; Zhu Z; Zhang J; Wang Z; Li J
    J Exp Clin Cancer Res; 2022 Feb; 41(1):48. PubMed ID: 35109895
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Promising Immunotherapy in Metastatic Testicular Sex Cord Stromal Tumours After First-Line Chemotherapy.
    Shang B; Cao C; Jiang W; Shi H; Bi X; Cui C; Shou J; Zheng S; Zhang J; Zhou A; Li C; Ma J
    Front Immunol; 2021; 12():720359. PubMed ID: 35082775
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Well-differentiated gastroenteropancreatic G3 NET: findings from a large single centre cohort.
    Lithgow K; Venkataraman H; Hughes S; Shah H; Kemp-Blake J; Vickrage S; Smith S; Humphries S; Elshafie M; Taniere P; Diaz-Cano S; Dasari BVM; Almond M; Ford S; Ayuk J; Shetty S; Shah T; Geh I
    Sci Rep; 2021 Sep; 11(1):17947. PubMed ID: 34504148
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Heat shock protein 47 confers chemoresistance on pancreatic cancer cells by interacting with calreticulin and IRE1α.
    Yoneda A; Minomi K; Tamura Y
    Cancer Sci; 2021 Jul; 112(7):2803-2820. PubMed ID: 34109710
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Pancreatic cancer Stem-Like Cells With High calreticulin Expression Associated With Immune Surveillance.
    Fujiwara Y; Tsunedomi R; Yoshimura K; Matsukuma S; Fujiwara N; Nishiyama M; Kanekiyo S; Matsui H; Shindo Y; Tokumitsu Y; Yoshida S; Iida M; Suzuki N; Takeda S; Ioka T; Hazama S; Nagano H
    Pancreas; 2021 Mar; 50(3):405-413. PubMed ID: 33835973
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Analyzing and predicting the LNM rate and prognosis of patients with intraductal papillary mucinous neoplasm of the pancreas.
    Tang CT; Liu BX; Chen Y; Zeng C
    Cancer Med; 2021 Mar; 10(6):1925-1935. PubMed ID: 33641255
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. calreticulin exposure correlates with robust adaptive antitumor immunity and favorable prognosis in ovarian carcinoma patients.
    Kasikova L; Hensler M; Truxova I; Skapa P; Laco J; Belicova L; Praznovec I; Vosahlikova S; Halaska MJ; Brtnicky T; Rob L; Presl J; Kostun J; Cremer I; Ryska A; Kroemer G; Galluzzi L; Spisek R; Fucikova J
    J Immunother Cancer; 2019 Nov; 7(1):312. PubMed ID: 31747968
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Unmasking a new prognostic marker and therapeutic target from the GDNF-RET/PIT1/p14ARF/p53 pathway in acromegaly.
    Chenlo M; Rodriguez-Gomez IA; Serramito R; Garcia-Rendueles AR; Villar-Taibo R; Fernandez-Rodriguez E; Perez-Romero S; Suarez-Fariña M; Garcia-Allut A; Cabezas-Agricola JM; Rodriguez-Garcia J; Lear PV; Alvarez-San Martin RM; Alvarez-Escola C; Bernabeu I; Alvarez CV
    EBioMedicine; 2019 May; 43():537-552. PubMed ID: 30975543
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.